The

Daily

Edition

View Previous Dates

September 9, 2019

Briefing

Around the nation: Hahnemann can sell its residency slots for $55M, judge rules

Why even doctors with opioid use disorder seldom get 'the gold standard' of care

As vaping illness deaths rise, public health officials are giving conflicting advice

Our take: How insurers are scrambling to cover multimillion-dollar gene therapies

Groupon is now selling CT scans. Is that 'bonkers'?

Medical imaging rates are climbing—despite efforts to bring them down

Are diet sodas dangerous? New research deepens the debate.

Weekly review: He died of an overdose—after $110,000 in addiction treatment

Print All Daily Briefing Article from

 09/09/2019

Have a Question?

x

Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

X
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.